We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
-12.71%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.6M
AUM Growth
-$7.12M
Cap. Flow
-$3.47M
Cap. Flow %
-14.14%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CRBU icon
Caribou Biosciences
CRBU
+$2.31M
2
ILMN icon
Illumina
ILMN
+$1.16M

Sector Composition

Rank Sector Weight
1 Miscellaneous 80.92%
2 Healthcare 19.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDX icon
1
VanEck Gold Miners ETF
GDX
$30.7B
$19.9M 80.92%
738,500
– –
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.33B
$3.64M 14.84%
602,272
– –
YMAB
3
DELISTED
Y-mAbs Therapeutics
YMAB
$1.04M 4.24%
191,176
– –
CRBU icon
4
Caribou Biosciences
CRBU
$168M
– –
-544,196
Closed -$2.31M
ILMN icon
5
Illumina
ILMN
$33B
– –
-6,360
Closed -$1.16M

Similar funds

BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Memorial Sloan Kettering Cancer Center's Q3 2023 Portfolio in Review

As of Q3 2023, Memorial Sloan Kettering Cancer Center held 5 positions worth $24.6M, down 22% from $31.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Memorial Sloan Kettering Cancer Center withdrew a net $3.47M in Q3 2023, closing 2 positions. Its most notable exit was Caribou Biosciences, an estimated $2.31M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, up from 70% a quarter earlier, followed by Healthcare.

  • Memorial Sloan Kettering Cancer Center fully exited Caribou Biosciences in Q3 2023, selling an estimated $2.31M.
  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $24.6M portfolio in Q3 2023.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 2 in Q3 2023.
  • Memorial Sloan Kettering Cancer Center's portfolio value fell 22% quarter-over-quarter to $24.6M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q3 2023, filed 14 Nov 2023.